TRNDi007-B

Registration Summary:

A P E C

iPSC HT521B

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	TRNDi007-B
Cite as:	TRNDi007-B (RRID:CVCL_UL27)
Alternative name(s)	iPSC HT521B
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	27th March 2019
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	NIH/NCATS-TRND Branch (TRND)
External Databases
Cellosaurus	CVCL_UL27
Wikidata	Q98133596
General Information
Publications	Corbett JL et al. iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery. Frontiers in medicine. 2019;6:265. Cheng YS et al. A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p.R854X mutation in the GAA gene. Stem cell research. 2019 May;37:101435. Chulpanova Daria S. et al. iPSCs for modeling lysosomal storage diseases. Recent Advances in iPSC Disease Modeling, Volume 1. 2020-00-00. Cheng YS et al. Modeling CNS Involvement in Pompe Disease Using Neural Stem Cells Generated from Patient-Derived Induced Pluripotent Stem Cells. Cells. 2020 Dec 22;10(1). Escribá R et al. Inborn errors of metabolism: Lessons from iPSC models. Reviews in endocrine & metabolic disorders. 2021 Dec;22(4):1189-1200. Zhang H et al. Case Report: Identification of Compound Heterozygous Mutations in a Patient With Late-Onset Glycogen Storage Disease Type II (Pompe Disease). Frontiers in neurology. 2022;13:839263. Aguilar-González A et al. Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies. International journal of molecular sciences. 2022 Jun 4;23(11). Christensen C et al. Generation of two induced pluripotent stem cell lines (CHOCi002-A and CHOCi003-A) from Pompe disease patients with compound heterozygous mutations in the GAA gene. Stem cell research. 2023 Jun;69:103117. Cheng Yu‐Shan et al. A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction. Current Protocols. 2023-08-00.

hIPSC Derivation

General